Invitris is a biotechnology company developing a universal technology platform called "Phactory" for cell-free protein synthesis. This platform enables the rapid, scalable, and cost-effective production of protein-based drugs, with an initial focus on synthetic bacteriophages and other antimicrobial proteins to combat antibiotic-resistant infections. The company aims to simplify drug development and manufacturing to address the global health threat of antimicrobial resistance.